Jinan High-Tech Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 27, 2021 at 02:39 pm
Share
Jinan High-tech Development Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 476.240 million compared to CNY 380.848 million a year ago. Operating loss was CNY 94.855 million compared to operating Income of CNY 48.202 million a year ago. Net loss was CNY 137.601 million compared to net income of CNY 46.927 million a year ago. Basic loss per share from continuing operations was CNY 0.16 compared to basic earnings per share from continuing operations of CNY 0.05 a year ago.
Jinan High-tech Development Co Ltd is a China-based company principally engaged in the in vitro diagnostics business. The Company operates three segments. The Real Estate and Property Services Business segment is mainly engaged in real estate development and sales and the provision of property and property leasing services. The In Vitro Diagnostics Business segment is mainly engaged in the research and development, production and sales of products such as molecular diagnostic reagents, molecular diagnostic automated testing equipment, biological sample library management software, biological sample intelligent storage cabinets, biological sample intelligent management terminals, and provides medical testing services. The products are mainly used in the fields of infectious disease prevention and control, pathogenic microorganism detection, food safety testing and other fields. The Other Business segment is mainly engaged in trading business and other businesses.